| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Nature Medicine (T.H., H.N., T.-T.Y., S.Y.), Department of International Health and Radiation Research (N.T., S.Y.), Atomic Bomb Disease Institute, Department of Pharmacology (Y.N.), Nagasaki University School of Medicine, Nagasaki, 852-8523, Japan; Kuma Hospital (S.F., K.K.), Kobe, 650, Japan; Ito Hospital (N.I., K.I.), Tokyo, 150, Japan
Address all correspondence and requests for reprints to: Hiroyuki Namba, MD, Associate Professor, Department of Nature Medicine, Atomic Bomb Disease Institute, Nagasaki University School of Medicine, 112-4 Sakamoto, Nagasaki 852, Japan. E-mail: namba{at}net.nagasaki-u.ac.jp
c-Jun N-terminal kinases (JNK) participate in cellular responses to mitogenic stimuli and environmental stresses. We investigated whether and how TSH, which promotes the proliferation and differentiation of thyroid cells, regulates JNK activity in primary cultured human thyroid cells. TSH stimulated JNK activity in cytosolic fractions of thyroid cells measured by in vitro kinase assay. A low concentration of TSH (10-11 M) stimulated JNK activity but at a higher dose (10-810-7 M), TSH suppressed JNK activity without any change of JNK protein level. Activation of JNK by TSH was also observed in CHO cells stably transfected with TSH receptor complementary DNA (cDNA), suggesting a ligand-receptor specific interaction. TSH stimulated JNK activity through a pertussis toxin-sensitive pathway. We next elucidated the signal transduction pathways in TSH-induced JNK activation by examining the involvement of four distinct intracellular signal molecules; protein kinase C (PKC), cAMP, Ca2+, and PI3-kinase. The stimulation of JNK by TSH was blocked by two PKC inhibitors and suppressed by 8-bromo-cAMP or forskolin. These findings demonstrate that TSH regulates JNK activity biphasically in human thyroid cells through an interaction between Gi-PKC and cAMP-PKA pathways.
This article has been cited by other articles:
![]() |
T. R. H. Buch, H. Biebermann, H. Kalwa, O. Pinkenburg, D. Hager, H. Barth, K. Aktories, A. Breit, and T. Gudermann G13-dependent Activation of MAPK by Thyrotropin J. Biol. Chem., July 18, 2008; 283(29): 20330 - 20341. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Vandeput, S. Perpete, K. Coulonval, F. Lamy, and J. E. Dumont Role of the Different Mitogen-Activated Protein Kinase Subfamilies in the Stimulation of Dog and Human Thyroid Epithelial Cell Proliferation by Cyclic Adenosine 5'-Monophosphate and Growth Factors Endocrinology, April 1, 2003; 144(4): 1341 - 1349. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Ellsworth, B. R. White, A. T. Burns, B. D. Cherrington, A. M. Otis, and C. M. Clay c-Jun N-Terminal Kinase Activation of Activator Protein-1 Underlies Homologous Regulation of the Gonadotropin-Releasing Hormone Receptor Gene in {alpha}T3-1 Cells Endocrinology, March 1, 2003; 144(3): 839 - 849. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Maher How Protein Kinase C Activation Protects Nerve Cells from Oxidative Stress-Induced Cell Death J. Neurosci., May 1, 2001; 21(9): 2929 - 2938. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Monno, M. V. Newman, M. Cook, and W. L. Lowe Jr. Insulin-Like Growth Factor I Activates c-Jun N-Terminal Kinase in MCF-7 Breast Cancer Cells Endocrinology, February 1, 2000; 141(2): 544 - 550. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |